Health officials support mRNA vaccines as AstraZeneca’s Covid vaccine sales decrease significantly
The sales of the Oxford AstraZeneca Covid vaccine have plummeted to zero as health officials shift their support to safer alternatives. In the three months leading up to June, the Anglo-Swedish pharmaceutical group recorded no sales for the vaccine, referred to as Vaxzevria, compared to $455 million (£350 million) in revenue during the same period …